LIMERICK BIOPHARMA Trademark

Trademark Overview


On Friday, April 9, 2010, a trademark application was filed for LIMERICK BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the LIMERICK BIOPHARMA trademark a serial number of 85010595. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 30, 2012. This trademark is owned by Limerick BioPharma, Inc.. The LIMERICK BIOPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of Tangiers disease, nonalcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), cystic fibrosis, human immunodeficiency virus (HIV), diabetes, hyperlipidemia, cancer, atherosclerosis, hypertension, insulin resistance, dyslipidemia, and hepatic cholestasis; pharmaceutical preparations for the treatment of the metabolic system, the central nervous system, the peripheral nervous system, the liver, the immune system, the renal system, and the cardiovascular system; pharmaceutical preparations for the treatment of metabolic diseases and disorders, infectious diseases, autoimmune diseases and disorders, inflammatory disorders, and cardiovascular disease; pharmaceutical preparations for the treatment of renal diseases, disorders and dysfunction; pharmaceutical preparations for the prevention and treatment of organ rejection; pharmaceutical preparations for use in tissue and organ transplantation, for adjuvant use in tissue and...
limerick biopharma

General Information


Serial Number85010595
Word MarkLIMERICK BIOPHARMA
Filing DateFriday, April 9, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 30, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 2, 2010

Trademark Statements


Disclaimer with Predetermined Text"BIOPHARMA"
Goods and Servicespharmaceutical preparations for the treatment of Tangiers disease, nonalcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), cystic fibrosis, human immunodeficiency virus (HIV), diabetes, hyperlipidemia, cancer, atherosclerosis, hypertension, insulin resistance, dyslipidemia, and hepatic cholestasis; pharmaceutical preparations for the treatment of the metabolic system, the central nervous system, the peripheral nervous system, the liver, the immune system, the renal system, and the cardiovascular system; pharmaceutical preparations for the treatment of metabolic diseases and disorders, infectious diseases, autoimmune diseases and disorders, inflammatory disorders, and cardiovascular disease; pharmaceutical preparations for the treatment of renal diseases, disorders and dysfunction; pharmaceutical preparations for the prevention and treatment of organ rejection; pharmaceutical preparations for use in tissue and organ transplantation, for adjuvant use in tissue and organ transplantation, for use in oncology, and for use in chemotherapy; pharmaceutical preparations and substances for the treatment of viral related diseases and disorders, and immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of pain; pharmaceuticals, namely, anti-infectives, immunosuppressants, anti-inflamatories, and antivirals; analgesic pharmaceutical preparations; anti-diabetic pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Pseudo MarkLIMERICK BIOLOGICAL PHARMACEUTICAL

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 14, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLimerick BioPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 940807031

Party NameLimerick BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 940807031

Trademark Events


Event DateEvent Description
Monday, July 30, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 30, 2012ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 19, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 18, 2012EXTENSION 2 GRANTED
Thursday, December 15, 2011EXTENSION 2 FILED
Wednesday, January 18, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 15, 2011TEAS EXTENSION RECEIVED
Tuesday, June 14, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 10, 2011EXTENSION 1 GRANTED
Friday, June 10, 2011EXTENSION 1 FILED
Friday, June 10, 2011TEAS EXTENSION RECEIVED
Tuesday, December 28, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 2, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 2, 2010PUBLISHED FOR OPPOSITION
Monday, September 27, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 27, 2010ASSIGNED TO LIE
Friday, September 17, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 15, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 15, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 15, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 21, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 21, 2010NON-FINAL ACTION E-MAILED
Wednesday, July 21, 2010NON-FINAL ACTION WRITTEN
Wednesday, July 14, 2010ASSIGNED TO EXAMINER
Thursday, April 15, 2010NOTICE OF PSEUDO MARK MAILED
Wednesday, April 14, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 13, 2010NEW APPLICATION ENTERED IN TRAM